Daily indoor light exposure: A spectral analysis of ambient light sources and its relevance to occupational dermatology To the Editor: There are few data characterizing the properties of daily ambient visible light surroundings. This introductory study sought to analyze the spectral signatures of ambient indoor light sources that surround people routinely during activities of daily living.
Spectra irradiance curves were recorded using a calibrated spectrometer (BLK C-SR XYZ123 UV-V spectrometer; StellarNet Inc, Tampa, FL). We analyzed various common sources of visible light encountered on a daily basis within the ambulatory care clinics and offices in the department of dermatology at our academic institution. We analyzed smartphones (Apple iPhone 6 Plus; Apple Inc, Cupertino, CA), tablets (Apple iPad Pro, Apple Inc), computer desktop monitors (Dell LCD monitor P2414HB; Dell Inc, Round Rock, TX), laptop screens (Dell Inspiron 15 3000 series; Dell Inc), large flatscreen televisions used for display (Sharp Aquos LC70LE745U, Sharp Electronics Corporation, Tokyo, Japan), office ceiling lights (Pentron 3500k 28w fp28/ 835/eco; OSRAM Sylvania, Wilmington, MA), clinic examination room ceiling lights (Pentron 3500k 28w fp28/835/eco, OSRAM Sylvania), office desktop lamps (CF23EL/mini, 2700K, OSRAM Sylvania), and A, iPhone 6 Plus white background, brightness 100%, 1 cm from the screen. B, Apple iPad Pro, white background, brightness 100%, 1 cm from the screen. C, Sharp Aquos lightemitting diode television screen, brightness 100%, 1 cm from the screen. D, Dell liquid crystal display desktop monitor, brightness 100%, 1 cm from the screen. E, Dell liquid crystal display desktop monitor, maximized exposure integration time. (The small peaks in the ultraviolet and deep infrared range are artefactual and not real. Given that the fluence output of the monitor was very small (as demonstrated above), in order to obtain a spectral curve we had to increase exposure integration time and zoom in on the display, hence the detection of artifact on the tail ends). F, Dell liquid crystal display laptop screen, brightness 100%, 1 cm from the screen. ambulatory surgical overhead lamps (Burton OP216SC; Philips Burton, Philips Lighting, Franklin Park, IL).
Light-emitting diode or liquid crystal display light sources, such as smartphone screens, tablets, laptop and desktop computer screens, and television displays, did not produce any detectable ultraviolet (UV) spectra. These light sources had a clear and crisp demarcation near 400 nm, below which no spectral irradiance was detected (Fig 1, A-F ). Light from fluorescent bulbs was found to have both ultraviolet A (UVA) and ultraviolet B light spectral signatures (Fig 2, A and C-E ) that disappeared as the spectrometer moved further away from the light source (Fig 2, B and F ) . Light from tungsten halogen bulb sources also emitted UVA, but the particular models we analyzed had been filtered by the manufacturer to remove UV and infrared wavelengths.
Although our data suggest that the emission of UV radiation decreases as distance from the given light source increases (this is expected because light intensity decreases as a proportionally to the inverse square of the emission radius, thus exposure integration time was increased and sources were rescanned to help identify the specific UV peak wavelength), the lack of UV spectra at further distances does not necessarily indicate that there is no UV radiation coming from the source. It simply indicates that the UV radiation intensity has fallen below a threshold detector count so that it no longer registers on the device. In reality, this does not factor in total radiation integrated over time. In other words, although UV irradiation may be minimal at far distances, in reality people are often indoors for several hours at a time; even a small amount of UV radiation exposure, integrated over many hours, each and every day, may add up to significant overall This was used to further delineate the specific UV peaks (the visible light peaks appear curved because of saturation of the spectrometer at such high exposure times, which was required to delineate the specific UV wavelengths). There is a clear UVA peak at 364 nm. E, Analysis of fluorescent tube bulb from ceiling light with maximized exposure integration time (same as 2 days). There is a clear UVB peak at 312 nm. F, Fluorescent tube bulb from ceiling lights, 50 cm away from the light source. At this distance, no UV spectra were detected. UV exposure. This may have previously overlooked clinical implications, particularly for patients with photosensitive dermatoses.
Our findings show the variability in spectral irradiances among light sources found in daily ambient indoor surroundings, highlighting the concern that the ever-increasing artificial light may have overt or clandestine effects on skin biology. Antimalarial therapy for granuloma annulare: Results of a retrospective analysis
To the Editor: Granuloma annulare (GA) is a relatively common granulomatous skin disease that most often presents as erythematous annular plaques with central clearing. Lesions may be localized (''localized GA''), widespread (''generalized GA''), or present as subcutaneous nodules (''subcutaneous GA''). GA is benign and largely asymptomatic. However, its epidemiology, comorbidities, and treatment protocols are poorly defined. 1 Published work often lacks comprehensive evaluation of GA cohorts, histologic confirmation, 1,2 or combines GA variants. Whereas antimalarials have been proposed in the treatment of GA, reports of their use are scarce, with the largest studies conducted decades ago. 1 To address these limitations, we retrospectively reviewed charts of all GA patients seen within the granulomatous skin disease clinic at the University of Pennsylvania (Penn) from 2009 to 2016 (by M.R.). Initial search criteria within PennSeek, a tool allowing querying of Penn's electronic medical records, required that patients either 1) received an International Classification of Diseases code for GA or 2) had ''GA'' or ''granuloma annulare'' written in their chart. This yielded 63 patients. A manual chart review identified 35 patients who were ultimately diagnosed with GA. All cases were histologically confirmed.
For each patient, the following information was retrieved (Table I) : demographics, GA clinical variant, antimalarial response, and the presence of comorbidities previously reported in association with GA. Treatment response was determined from clinical notes. Table I describes the characteristics of our GA cohort. Eighty percent were female; the mean age at diagnosis was 54 years (range, 28-79 years). More than three-quarters (77.1%) of patients had generalized GA (n ¼ 27), 17.1% had localized GA (n ¼ 6), and 5.7% had subcutaneous GA (n ¼ 2). Five patients had features of annular elastolytic giant cell granuloma.
The prevalence of diabetes, dyslipidemia, and hypothyroidism is the United States is estimated at 17.5% ( for patients 45-64 years of age), 3 29.4% ( for patients 55-64 years of age without cardiovascular disease), 4 and 6.1% ( for patients 50-59 years of age), 5 respectively. In contrast, our GA cohort was of a similar age group, yet had a higher prevalence of these comorbidities. More than half (63.2%) had some form of glucose intolerance; 31.6% were diabetic. Eighty percent had dyslipidemia and 37% had thyroid disease. Ten of 18 patients (55.6%) improved on hydroxychloroquine (Fig 1) . Nearly all patients prescribed hydroxychloroquine had previously failed or experienced inadequate response from alternative GA treatments, the most common of which were topical steroids (n ¼ 12), intralesional triamcinolone acetonide (n ¼ 10), topical tacrolimus (n ¼ 5), and minocycline (n ¼ 5). All 6 patients prescribed chloroquine improved (100%), 5 of whom had earlier failed treatment with hydroxychloroquine. The average treatment duration with hydroxychloroquine and chloroquine before noting improvement was 3.6 and 3 months, respectively. Our study is limited by its small size, the lack of standardized tools available to assess GA severity and treatment efficacy, and its retrospective cross-sectional nature. To our knowledge, this is the largest cohort of GA patients treated with hydroxychloroquine, and further emphasizes the potential association of GA with thyroid disease. 1 Notably, our tertiary referral cohort included predominantly patients with generalized GA, while 70% of GA cases are localized in general practice. 1 
